WASHINGTON, Jan 17 (Reuters) - U.S. Health and Human
Services Secretary Xavier Becerra said on Friday the government
will try to negotiate better prices for the 15 drugs targeted
for Medicare price negotiations for 2027 because they are too
expensive.
"The reason we're going to negotiate for lower prices of
these 15 drugs, the way we did last year for the 10 most
expensive drugs, is because the facts show that not only do they
work, but those drugs are too expensive and should be lowered in
price," Becerra said in an interview with CNN.